Abbott Laboratories said on Monday it and DexCom have reached an agreement to settle all patent disputes between the ...

There has been no shortage of news covered across the diabetes and drug delivery markets over the course of 2024.

Abbott (ABT) ended the recent trading session at $114.76, demonstrating a +0.39% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 1.1%.

Abbott has completed the first-in-human procedures for leadless left bundle branch area pacing (LBBAP) using its AVEIR ...

Abbott Laboraties announced its plan to spin off the drug division in October 2011. It will retain its name and focus on diversified medicinal products, while its spin-off company, AbbVie ...

In the closing of the recent trading day, Abbott (ABT) stood at $114.14, denoting a -1.18% change from the preceding trading day.

Abbott India launched PneumoShield 14, a pneumonia vaccine for children aged six weeks and older. This vaccine offers broader protection than existing vaccines by covering 14 pneumococcal strains, ...

Abbott announces first in-world leadless pacing procedures in the left bundle branch area of the heart: Abbott Park, Illinois Thursday, December 19, 2024, 15:00 Hrs [IST] Abbott a ...

Lucas' father, who was staying with the family after being down on his luck, reportedly stole the Christmas presents and ...

New Delhi: Abbott Healthcare has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to manufacture and market Ursodeoxycholic ...